Home/LDN Therapy/Blog/LDN and Autoimmune Disease: What the Research Shows
ResearchSeptember 3, 2026·7 min read

LDN and Autoimmune Disease: What the Research Shows

G
Gregg MacDonald, APRN
Pineapple Primary Care

Autoimmune disease affects tens of millions of Americans. Whether it's Multiple Sclerosis, Crohn's disease, rheumatoid arthritis, or Hashimoto's thyroiditis, the common thread is an immune system that has turned against the body's own tissues.

Conventional treatment often involves immunosuppressive drugs that carry significant side effects and long-term risks. LDN offers a different approach — immune modulation rather than immune suppression.

The Core Mechanism

The key distinction with LDN is that it doesn't broadly suppress immune function. Instead, it appears to normalize it — calming overactivity in specific immune pathways while leaving protective immune responses intact.

This matters because many patients with autoimmune disease are reluctant to suppress their immune system further, particularly given the infection risks. LDN's immunomodulatory profile is fundamentally different from methotrexate, biologics, or corticosteroids.

Multiple Sclerosis

MS has the strongest evidence base for LDN of any autoimmune condition. A landmark pilot trial by Dr. Jarred Younger at Stanford found that LDN significantly improved quality of life in MS patients, reducing fatigue and improving mental health scores with minimal side effects.

The LDN Research Trust has collected thousands of patient testimonials from people with MS reporting improvements in fatigue, spasticity, bladder function, and cognitive clarity. A Norwegian documentary featuring MS patients on LDN sparked widespread European interest in the treatment.

Crohn's Disease

A small but well-designed clinical trial by Dr. Jill Smith at Penn State found that LDN produced remission in 88% of pediatric Crohn's patients — a remarkable result. Follow-up adult studies have shown similar promise, with LDN reducing inflammatory markers and improving quality of life.

For Crohn's patients who have exhausted or wish to avoid biologic therapies, LDN represents a compelling, low-cost option worth discussing with their provider.

Hashimoto's Thyroiditis

Hashimoto's — an autoimmune attack on the thyroid gland — affects an estimated 14 million Americans, the majority of them women. Many patients on thyroid hormone replacement still struggle with fatigue, brain fog, and poor quality of life.

LDN's immunomodulatory effects may help reduce the ongoing autoimmune attack on the thyroid, potentially slowing disease progression and improving symptoms. Dr. Izabella Wentz, a well-known thyroid pharmacist and patient advocate, has written extensively about LDN for Hashimoto's.

Rheumatoid Arthritis and Other Conditions

Preliminary evidence and patient reports suggest benefit in rheumatoid arthritis, lupus, psoriatic arthritis, and ankylosing spondylitis. While large randomized controlled trials are still needed, the consistent pattern across conditions points to LDN's broad immunomodulatory potential.

The Practical Takeaway

LDN is not a replacement for conventional care in autoimmune disease — it's a complement. Many patients take it alongside their existing medications (with the exception of opioids). The cost is low, the side effect profile is favorable, and the potential benefit — for the right patient — can be significant.

If you have an autoimmune condition and want to discuss whether LDN belongs in your treatment plan, we'd welcome the conversation.

Questions About LDN?

Book a free telehealth consultation with Pineapple Primary Care to discuss whether LDN is right for your situation. Available throughout Florida.

Book a Free LDN Consultation

Low Dose Naltrexone (LDN) is not FDA-approved for any indication. While naltrexone is an FDA-approved medication at standard doses for opioid and alcohol dependence, the use of naltrexone at low doses is considered off-label prescribing. This website provides educational information about LDN based on published clinical literature and patient experiences. Any discussion or consideration of LDN therapy should occur only in consultation with a qualified healthcare provider who can evaluate your individual medical history, current medications, and clinical circumstances. Pineapple Primary Care does not guarantee any specific outcome from LDN therapy and assumes no liability for decisions made based on this information. Always consult with your healthcare provider before starting, stopping, or modifying any medication.